Get the Stockscreener App
5.37
0.00%
0.00
After Hours:
5.37
Curevac N V stock is traded at $5.37, with a volume of 321.22K.
It is up +0.00% in the last 24 hours and down -0.74% over the past month.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
See More
Previous Close:
$5.37
Open:
$5.37
24h Volume:
321.22K
Relative Volume:
0.27
Market Cap:
$1.20B
Revenue:
$596.48M
Net Income/Loss:
$123.72M
P/E Ratio:
9.7921
EPS:
0.5484
Net Cash Flow:
$106.59M
1W Performance:
-1.29%
1M Performance:
-0.74%
6M Performance:
+75.49%
1Y Performance:
+66.77%
1-Day Range:
$5.36
$5.39
1-Week Range:
$5.36
$5.45
52-Week Range:
$2.37
$5.72
Curevac N V Stock (CVAC) Company Profile
Compare CVAC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVAC
Curevac N V
|
5.37 | 1.21B | 596.48M | 123.72M | 106.59M | 0.5484 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Curevac N V Stock (CVAC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-13-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-25-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-08-23 | Initiated | SVB Securities | Outperform |
| Jan-19-23 | Upgrade | UBS | Neutral → Buy |
| Jan-09-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-21-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-18-22 | Initiated | JMP Securities | Mkt Outperform |
| Oct-22-21 | Initiated | Deutsche Bank | Hold |
| Jun-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-26-21 | Resumed | Credit Suisse | Underperform |
| Apr-26-21 | Initiated | Guggenheim | Neutral |
| Dec-10-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-08-20 | Initiated | BofA Securities | Buy |
| Sep-08-20 | Initiated | Credit Suisse | Neutral |
| Sep-08-20 | Initiated | Jefferies | Hold |
View All
Curevac N V Stock (CVAC) Latest News
CureVac N.V. recovery potential after sell off2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
Institutional scanner results for CureVac N.V.Portfolio Update Summary & Daily Technical Stock Forecast Reports - Newser
Real time alert setup for CureVac N.V. performanceInsider Selling & Fast Gain Swing Alerts - Newser
Developing predictive dashboards with CureVac N.V. dataTrade Ideas & Community Trade Idea Sharing - Newser
Automated trading signals detected on CureVac N.V.Quarterly Profit Review & Reliable Price Action Trade Plans - Newser
What does recent volatility data suggest for CureVac N.V.Market Sentiment Report & Community Trade Idea Sharing Platform - Newser
Key metrics from CureVac N.V.’s quarterly dataWeekly Profit Report & Daily Chart Pattern Signals - Newser
Measuring CureVac N.V.’s beta against major indices2025 Fundamental Recap & Expert Curated Trade Setup Alerts - Newser
Should you wait for a breakout in CureVac N.V.Trade Signal Summary & Growth Oriented Trading Recommendations - Newser
CureVac N.V. stock outlook for YEARNew Guidance & Verified Momentum Watchlists - Newser
Does CureVac N.V. qualify in momentum factor screening2025 Technical Patterns & Free Fast Entry Momentum Trade Alerts - Newser
Is CureVac N.V. stock bottoming outEarnings Growth Summary & Weekly Chart Analysis and Guides - Newser
Is a relief rally coming for CureVac N.V. holdersJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - Newser
Price Reversal in CureVac N.V. Traders Watch CloselyQuarterly Growth Report & Daily Stock Trend Watchlist - beatles.ru
Forecasting CureVac N.V. price range with options dataJuly 2025 Breakouts & Verified High Yield Trade Plans - Newser
What Fibonacci levels say about CureVac N.V. reboundBull Run & Safe Capital Growth Plans - Newser
Ranking CureVac N.V. among high performing stocks via tools2025 Market Overview & Daily Price Action Insights - Newser
Can a trend reversal in CureVac N.V. lead to recoveryGDP Growth & Step-by-Step Trade Execution Guides - Newser
CureVac N.V. Testing Reversal Zone on Weekly Chart getLinesFromResByArray error: size == 0 - kangso.co.kr
CureVac N.V. stock daily chart insights2025 Market Overview & Verified High Yield Trade Plans - Newser
Published on: 2025-08-29 02:26:04 - Newser
Short Interest Drops in CureVac N.V. After Rally getLinesFromResByArray error: size == 0 - thegnnews.com
Curevac N V Stock (CVAC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):